{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:12:42Z","timestamp":1787940762454,"version":"build-2784847793"},"update-to":[{"DOI":"10.1002\/14651858.cd010290.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T00:00:00Z","timestamp":1547596800000}}],"reference-count":60,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010290.pub3","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T06:41:50Z","timestamp":1547620910000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Gonadotrophins for ovulation induction in women with polycystic ovary syndrome"],"prefix":"10.1002","volume":"2019","author":[{"given":"Nienke S","family":"Weiss","sequence":"first","affiliation":[{"name":"Amsterdam UMC, Free Medical University; Center for Reproductive Medicine; De Boelelaan 1105 Amsterdam Netherlands 1081 HV"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Kostova","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam; Center for Reproductive Medicine; Meibergdreef 9 Amsterdam Netherlands 1105 AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"Nahuis","sequence":"additional","affiliation":[{"name":"VU University Medical Center; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben Willem J","family":"Mol","sequence":"additional","affiliation":[{"name":"Monash University; Department of Obstetrics and Gynaecology; 246 Clayton Road Clayton Victoria Australia 3168"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulco","family":"van der Veen","sequence":"additional","affiliation":[{"name":"Amsterdan UMC, University of Amsterdam; Center for Reproductive Medicine; Meibergdreef 9 Amsterdam Netherlands 1105 AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelon","family":"van Wely","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam; Center for Reproductive Medicine; Meibergdreef 9 Amsterdam Netherlands 1105 AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,1,16]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD010290.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/humrep\/dem075","article-title":"Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial","volume":"22","author":"Balen","year":"2007","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD010290.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0015-0282(97)00423-8","article-title":"Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene-resistant, normogonadotropic, chronic anovulation; a prospective, multicenter, assessor-blind, randomized, clinical trial","volume":"69","author":"Coelingh Bennink","year":"1998","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD010290.pub3-BIB0003|cit3","first-page":"297","article-title":"A new highly purified human-derived FSH, Bravelle, is as effective and well tolerated as recombinant follitropin beta in ovulation induction in infertile women with ovulatory dysfunction","volume":"19","author":"Feigenbaum","year":"2001","journal-title":"Today's Therapeutic Trends"},{"issue":"5","key":"10.1002\/14651858.CD010290.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2265.1990.tb03896.x","article-title":"Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease","volume":"33","author":"Gadir","year":"1990","journal-title":"Clinical Endocrinology"},{"issue":"5","key":"10.1002\/14651858.CD010290.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1472-6483(10)61632-X","article-title":"Ovulation induction with urinary FSH or recombinant FSH in polycystic ovary syndrome patients: a prospective randomized analysis of cost-effectiveness","volume":"9","author":"Gerli","year":"2004","journal-title":"Reproductive BioMedicine Online"},{"issue":"1","key":"10.1002\/14651858.CD010290.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/humrep\/11.suppl_5.95","article-title":"Clinical assessment of human gonadotrophins produced by recombinant DNA technology","volume":"11","author":"Loumaye","year":"1996","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD010290.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0015-0282(16)53511-0","article-title":"Treatment of clomiphene citrate-resistant polycystic ovarian syndrome with pure follicle-stimulating hormone or human menopausal gonadotropin","volume":"53","author":"McFaul","year":"1990","journal-title":"Fertility and Sterility"},{"issue":"7","key":"10.1002\/14651858.CD010290.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/humrep\/del085","article-title":"Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study","volume":"21","author":"Platteau","year":"2006","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD010290.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1477-7827-4-38","article-title":"Recombinant versus highly-purified, urinary follicle-stimulating hormone (rFSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis","volume":"4","author":"Revelli","year":"2006","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD010290.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0015-0282(16)54059-X","article-title":"A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome","volume":"55","author":"Sagle","year":"1991","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD010290.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0015-0282(16)48551-1","article-title":"Ovulatoin induction in polycystic ovary syndrome with urinary follicle-stimulating hormone or human menopausal gonadotropin","volume":"43","author":"Seibel","year":"1985","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD010290.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/09513590310001651731","article-title":"Low-dose ovulation induction with urinary gonadotrophins or recombinant follicle stimulating hormone in patients with polycystic ovary syndrome","volume":"18","author":"Szil\u00e1gyi","year":"2004","journal-title":"Gynaecological Endocrinology"},{"key":"10.1002\/14651858.CD010290.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12522-010-0046-5","article-title":"Recombinant follicle stimulating hormone (follitropin alfa) versus purified urinary follicle stimulating hormone in a low dose step-up regimen to induce ovulation in Japanese women with anti-estrogen-ineffective oligo- or anovulatory infertility","volume":"9","author":"Taketani","year":"2010","journal-title":"Reproductive Medicine and Biology"},{"issue":"10122","key":"10.1002\/14651858.CD010290.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"758-65","DOI":"10.1016\/S0140-6736(17)33308-1","article-title":"Gonadotrophins versus clomiphene citrate with or without intrauterine insemination in women with normogonadotropic anovulation and clomiphene failure (M-OVIN): a randomised, two-by-two factorial trial","volume":"391","author":"Weiss","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD010290.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0015-0282(99)00209-5","article-title":"Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective randomized study","volume":"72","author":"Yarali","year":"1999","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD010290.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.humrep.a137035","article-title":"Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries","volume":"5","author":"Homburg","year":"1990","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD010290.pub3-BIB0017|cit17","first-page":"303","article-title":"Profertility uses of LHRH agonist analogues","volume-title":"LHRH and its Analogues; Contraceptive and Therapeutic Application. Part 2","author":"Jacobs","year":"1987"},{"issue":"3","key":"10.1002\/14651858.CD010290.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0015-0282(16)53335-4","article-title":"Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovarian syndrome","volume":"53","author":"Larsen","year":"1990","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD010290.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000435773","article-title":"Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin in intrauterine insemination: a randomized clinical trial in polycystic ovary syndrome-associated infertility","volume":"81","author":"Rashidi","year":"2016","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"4","key":"10.1002\/14651858.CD010290.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/humrep\/deh185","article-title":"Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial","volume":"19","author":"Ricci","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD010290.pub3-BIB0021|cit21","unstructured":"Zhou YZ Shen H Zuo WL Xu YH Deng XH Chen YL A randomized, single-blind, parallel-controlled and multicentre study: compare the efficacy and safety of domestic and imported human recombinant FSH in WHO group II anovulatory infertility Chung-Hua Fu Chan Ko Tsa Chih (Chinese Journal of Obstetrics & Gynecology) 2016 258 63"},{"issue":"Suppl_1","key":"10.1002\/14651858.CD010290.pub3-BIB0022|cit22","first-page":"i304","article-title":"A randomized trial comparing the efficacy and safety of rFSH + rLH versus rFSH alone and HMG to induce ovulation in cycles for low complexity techniques","volume":"31","author":"Bejarano Vel\u00e1zquez","year":"2016","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD010290.pub3-BIB0023|cit23","unstructured":"NCT01923194 Evaluation of efficacy and safety of highly purified urofollitropin for ovulation induction in Chinese females (Compass) clinicaltrials.gov\/ct2\/show\/NCT01923194"},{"issue":"6543","key":"10.1002\/14651858.CD010290.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bmj.293.6543.355","article-title":"Prevelance of polycystic ovaries in women with anovulation and idiopathic hirsutism","volume":"293","author":"Adams","year":"1986","journal-title":"British Medical Journal (Clinical Research ed.)"},{"issue":"8","key":"10.1002\/14651858.CD010290.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/oxfordjournals.humrep.a019459","article-title":"Pregnancy and birth in an in-vitro fertilization cycle after controlled ovarian stimulation in a women with a history of allergic reaction to human menopausal gonadotrophin","volume":"11","author":"Albano","year":"1996","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD010290.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1472-6483(10)62135-9","article-title":"FSH isoform composition of commercial gonadotrophin preparations: a neglected aspect?","volume":"9","author":"Andersen","year":"2004","journal-title":"Reproductive Biomedicine Online"},{"issue":"2","key":"10.1002\/14651858.CD010290.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0304-4157(88)90012-3","article-title":"Pituitary glycoprotein hormone oligosaccharides: structure, synthesis and function of asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropin","volume":"947","author":"Baenziger","year":"1988","journal-title":"Biochimica et Biophysica Acta"},{"issue":"1-2","key":"10.1002\/14651858.CD010290.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mce.2012.10.008","article-title":"Ovulation induction in the management of anovulatory polycystic ovary syndrome","volume":"373","author":"Balen","year":"2013","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD010290.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/humrep\/14.6.1418","article-title":"What are the clinical benefits of recombinant gonadotrophins? Recombinant follicle stimulating hormone","volume":"14","author":"Bergh","year":"1999","journal-title":"Human Reproduction"},{"issue":"10","key":"10.1002\/14651858.CD010290.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/oxfordjournals.humrep.a138345","article-title":"Allergenic potential of gonadotrophic preparations in experimental animal: Relevance of purity","volume":"9","author":"Biffoni","year":"1994","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD010290.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/molehr\/2.5.361","article-title":"Structure-function relationship of recombinant follicle stimulating hormone (Puregon)","volume":"2","author":"Leeuw","year":"1996","journal-title":"Molecular Human Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD010290.pub3-BIB0032|cit32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001122.pub4","article-title":"Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome","author":"Farquhar","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD010290.pub3-BIB0033|cit33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010287.pub3","article-title":"Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome","author":"Franik","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD010290.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1210\/jcem-18-12-1333","article-title":"Clinical effect of human pituitary follicle-stimulating hormone (FSH)","volume":"18","author":"Gemzell\u00a0CA","year":"1958","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD010290.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","article-title":"Ovarian hyperstimulation syndrome: an update review","volume":"44","author":"Golan","year":"1989","journal-title":"Obstetrical & Gynecological Survey"},{"key":"10.1002\/14651858.CD010290.pub3-BIB0036|cit36","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"key":"10.1002\/14651858.CD010290.pub3-BIB0037|cit37","first-page":"20","article-title":"Glycoprotein gonadotrophins. Structure and synthesis","volume":"288","author":"Gray","year":"1988","journal-title":"Acta Endocrinologica. Supplementum"},{"issue":"1","key":"10.1002\/14651858.CD010290.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1432-1033.1990.tb19332.x","article-title":"Isolation and structure determination of the intact sialylated N-linked carbohydrate chains of recombinant human follitropin (hFSH) expressed in Chinese hamster ovary cells","volume":"193","author":"Hard","year":"1990","journal-title":"European Journal of Biochemistry"},{"issue":"7414","key":"10.1002\/14651858.CD010290.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010290.pub3-BIB0040|cit40","unstructured":"Higgins JPT Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD010290.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/humupd\/2.2.172","article-title":"Genetic engineering of human FSH (Gonal F)","volume":"2","author":"Howles","year":"1996","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD010290.pub3-BIB0042|cit42","article-title":"Gonadotrophin therapy","volume-title":"Female Infertility","author":"Jewelewicz","year":"1973"},{"issue":"9","key":"10.1002\/14651858.CD010290.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1016\/S0021-9258(18)83656-0","article-title":"Expression of biologically active human follitropin in Chinese hamster ovary cells","volume":"264","author":"Keene","year":"1989","journal-title":"Journal of Biological Chemistry"},{"issue":"7","key":"10.1002\/14651858.CD010290.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/oxfordjournals.humrep.a136208","article-title":"In-vitro biopotency and glycoform distribution of recombinant human follicle stimulating hormone (Org 32489), Metrodin and Metrodin-HP","volume":"10","author":"Lambert","year":"1995","journal-title":"Human Reproduction"},{"issue":"7400","key":"10.1002\/14651858.CD010290.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bmj.326.7400.1167","article-title":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review","volume":"326","author":"Lexchin","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010290.pub3-BIB0046|cit46","first-page":"213","article-title":"Clinical effects of a human postmenopausal gonadotropin","volume":"59","author":"Lunenfeld","year":"1960","journal-title":"La Rassegna di Clinica, Terapia e Scienze Affini"},{"key":"10.1002\/14651858.CD010290.pub3-BIB0047|cit47","first-page":"205","article-title":"Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile women","volume":"1","author":"Nahuis","year":"2009","journal-title":"International Journal of Women's Health"},{"key":"10.1002\/14651858.CD010290.pub3-BIB0048|cit48","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"1","key":"10.1002\/14651858.CD010290.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD010290.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"Part 3","key":"10.1002\/14651858.CD010290.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1042\/bj2870665","article-title":"Molecular structures of glycoprotein hormones and functions of their carbohydrate components","volume":"287","author":"Stockell Hartree","year":"1992","journal-title":"Biochemical Journal"},{"issue":"5","key":"10.1002\/14651858.CD010290.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/humrep\/deg133","article-title":"Common statistical errors in the design and analysis of subfertility trials","volume":"18","author":"Vail","year":"2003","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD010290.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"j138","DOI":"10.1136\/bmj.j138","article-title":"Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis","volume":"356","author":"Wang","year":"2017","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010290.pub3-BIB0054|cit54","first-page":"43","article-title":"Isoforms of human gonadotrophins under different physiological conditions","volume-title":"Gonadotrophin Isoforms: Facts and Future","author":"Wide","year":"1997"},{"issue":"1","key":"10.1002\/14651858.CD010290.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1677\/joe.0.1250003","article-title":"Gonadotrophin glycosylation and function","volume":"125","author":"Wilson","year":"1990","journal-title":"Journal of Endocrinology"},{"key":"10.1002\/14651858.CD010290.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2265.1980.tb02132.x","article-title":"The polycystic ovary syndrome","volume":"12","author":"Yen","year":"1980","journal-title":"Clinical Endocrinology"},{"issue":"10","key":"10.1002\/14651858.CD010290.pub3-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008046.pub4","article-title":"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology","author":"Youssef","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD010290.pub3-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002121.pub2","article-title":"Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome","author":"Bayram","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD010290.pub3-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000410.pub2","article-title":"Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome","author":"Nugent","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD010290.pub3-BIB0060|cit60","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010290.pub2","article-title":"Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome","author":"Weiss","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd010290.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD010290.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,9]],"date-time":"2023-04-09T23:03:01Z","timestamp":1681081381000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010290.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,16]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010290.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,16]]}}}